In particular, the ACE I/D polymorphism was not associated with blood pressure response to ACE inhibitor (perindopril) treatment, or with the long-term risk of stroke and cardiac events, in 5,688 participants to the PROGRESS trial [257]. Here, ACE is linked to Stroke.